229 related articles for article (PubMed ID: 13915950)
1. The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri.
SPRINZ H; KUNDEL DW; DAMMIN GJ; HOROWITZ RE; SCHNEIDER H; FORMAL SB
Am J Pathol; 1961 Dec; 39(6):681-95. PubMed ID: 13915950
[No Abstract] [Full Text] [Related]
2. Experimental Shigella infections. V. Studies in germ-free guinea pigs.
FORMAL SB; DAMMIN G; SPRINZ H; KUNDEL D; SCHNEIDER H; HOROWITZ RE; FORBES M
J Bacteriol; 1961 Aug; 82(2):284-7. PubMed ID: 13700794
[TBL] [Abstract][Full Text] [Related]
3. ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN.
FORMAL SB; LABREC EH; KENT TH; FALKOW S
J Bacteriol; 1965 May; 89(5):1374-82. PubMed ID: 14293011
[TBL] [Abstract][Full Text] [Related]
4. Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.
FRETER R
J Exp Med; 1956 Sep; 104(3):411-8. PubMed ID: 13357693
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
[TBL] [Abstract][Full Text] [Related]
6. Self-experiments with ingestion of various bacteria.
Rédey B
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):45-62. PubMed ID: 4216252
[No Abstract] [Full Text] [Related]
7. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Barry EM; Wang J; Wu T; Davis T; Levine MM
Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice.
Filho-Lima JV; Vieira EC; Nicoli JR
J Appl Microbiol; 2000 Mar; 88(3):365-70. PubMed ID: 10747216
[TBL] [Abstract][Full Text] [Related]
9. Experimental Shigella infections in laboratory animals. I. Antagonism by human normal flora components in gnotobiotic mice.
Maier BR; Hentges DJ
Infect Immun; 1972 Aug; 6(2):168-73. PubMed ID: 4631914
[TBL] [Abstract][Full Text] [Related]
10. Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens.
Gemski P; Sheahan DG; Washington O; Formal SB
Infect Immun; 1972 Aug; 6(2):104-11. PubMed ID: 4569915
[TBL] [Abstract][Full Text] [Related]
11. Interaction between Escherichia coli and Shigella flexneri in the digestive tract of "gnotobiotic" mice.
Ducluzeau R; Raibaud P
Infect Immun; 1974 Apr; 9(4):730-3. PubMed ID: 4595761
[TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of the effect of polymyxin and monomycin on dysentery bacteria and enteropathogenic Coli bacteria in experiments and clinical cases].
Khodalevich IV
Antibiotiki; 1972 Mar; 17(3):222-4. PubMed ID: 4337880
[No Abstract] [Full Text] [Related]
13. Application of experimental keratoconjunctivitis shigellosa in chemotherapeutic evaluation of rifampicin to bacillary dysentery.
Osada Y; Nakajo M; Ogawa H
Jpn J Microbiol; 1972 Jul; 16(4):329-32. PubMed ID: 4569214
[No Abstract] [Full Text] [Related]
14. Development of antisera to detect virulent Yersinia enterocolitica, Shigella and Escherichia coli enteroinvasive.
Giannini MJ; de Medeiros BM; Bauab TM; Carlos IZ; de Toledo MR; Trabulsi LR; Falcão DP
Contrib Microbiol Immunol; 1991; 12():164-70. PubMed ID: 1935085
[No Abstract] [Full Text] [Related]
15. Mixed bacterial infections in relation to antibiotic activities. IV. Shigella-Escherichia coli infections.
FRIEDMAN DR; HALBERT SP
J Immunol; 1960 Jan; 84():11-9. PubMed ID: 13825099
[No Abstract] [Full Text] [Related]
16. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
[No Abstract] [Full Text] [Related]
17. Case report on a swift shift in uropathogens from Shigella flexneri to Escherichia coli: a thin line between bacterial persistence and reinfection.
Tufon KA; Fokam DPY; Kouanou YS; Meriki HD
Ann Clin Microbiol Antimicrob; 2020 Jul; 19(1):31. PubMed ID: 32727466
[TBL] [Abstract][Full Text] [Related]
18. Experimental Shigella infections. VI. Role of the small intestine in an experimental infection in guinea pigs.
FORMAL SB; ABRAMS GD; SCHNEIDER H; SPRINZ H
J Bacteriol; 1963 Jan; 85(1):119-25. PubMed ID: 13958748
[TBL] [Abstract][Full Text] [Related]
19. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.
Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R
Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598
[No Abstract] [Full Text] [Related]
20. [A possible way of improving colibacterin].
Shatilo VA; Bondarenko VM
Mikrobiol Zh (1978); 1984; 46(1):61-6. PubMed ID: 6401093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
